Tag:
Zicam
Latest Headlines
Latest Headlines
Supremes question Matrixx's disclosure arguments
We'll have to wait to hear arguments on the Supreme Court cases accepted yesterday. But while we were talking about those cases, which involve prescription data-mining and drug-discount litigation,
When can investors sue over side-effect disclosures?
When the U.S. Supreme Court hears a Matrixx Labs appeal in a class-action shareholder suit, it could give drugmakers some real guidance about disclosing drug side effects to investors. Matrixx
Supremes to hear appeal on Zicam class-action
The U.S. Supreme Court will hear an appeal by Matrixx Initiatives (MTXX.O) of a ruling that reinstated a class-action shareholder lawsuit over its Zicam cold treatment. Report
Matrixx withheld 800 complaints on Zicam
Matrixx Initiatives may profess its surprise at the FDA's warning against its Zicam cold-care products, but the company admits it held onto 800 consumer complaints about side effects linked to the
